Who are Bluewhale's investors?

Bluewhale's investors include Ascendo Ventures, Novalis LifeSciences, Baselayer Capital, Cardano, Ghaf Capital Partners, gumi Inc, PRIMAL CAPITAL, SBI Ven Capital and 1 more.

How much funding has Bluewhale raised?

Bluewhale has disclosed $5M raised across 1 of its 2 known rounds.

Where is Bluewhale headquartered?

Bluewhale is headquartered in Philadelphia, US.

Bluewhale

Philadelphia, US · Founded 2022 · Delaware corporation · 17 known investors

Find your way into Bluewhale

111 people in our graph share verified history with the Bluewhale team — schools, employers, funds. One of them is your warm intro.

Helge Daebelunlockedknows Peter Keller · together at Karlsruhe Institute of Technology (KIT) (overlapped)

×11knows the team · via Karlsruhe Institute of Technology (KIT)

BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs. The company serves medical institutions and therapeutics developers working with cell therapy products.

Biotech Deep Tech Medical Devices

Founders & leadership

Peter Keller inExecutivePeter Keller has held leadership positions at Abbott Laboratories, Solvay Pharmaceuticals, and McKinsey & Co., and has been involved in founding or leading biotech companies including Monopteros Therapeutics, Divide & Conquer, Aelin Therapeutics, Disarm Therapeutics (acquired by Eli Lilly), Inventiva, and Selecta Biosciences.

Board

Paul MeisterBoard directorPartner at Novalis LifeSciences

Elaine HeronBoard director

Paula CannonBoard director

Beate Mueller-TiemannBoard director

Investors · 17

Ascendo VenturesSeoul

Novalis LifeSciencesPortsmouth

Baselayer CapitalreportedMiami · $500K

Cardanoreported

Ghaf Capital PartnersreportedDubai

gumi Increported

PRIMAL CAPITALreportedTokyo

SBI Ven CapitalreportedSingapore · $1.1M – $20M

Spyre CapitalreportedBrendale

Also in the syndicate · 8

AnimocaAzimutMomentum6MZ CryptoNxGenSBIleadSBI DecimaleadSygnum

Funding

SEC filings, press & company announcements

$5M disclosed across 1 of 2 rounds · 2024–2025

Undisclosed amountseed fundingMar 2024
SBI (lead), SBI Decima (lead), SBI Ven Capital (lead), Animoca, Azimut, Baselayer Capital, Cardano, Ghaf Capital Partners, Gumi, Momentum6, MZ Crypto, NxGen, Primal Capital, Spyre Capital, Sygnum
Source ↗

▶$5MraisedOct 2025 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Elaine HeronDirector
Peter KellerExecutive Officer, Director
Paul MeisterDirector
Paula CannonDirector
Beate Mueller-TiemannDirector

Offering amount: $15M
Amount sold: $5M
First sale: Oct 2025
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Bluewhale Secures $7 Million in Seed Roundthesaasnews.com · Mar 2024

▸Research sources · 5

primary sources listed

Blue Whale Acquisition Corp I Announces Closing of $200,000,000 Initial Public Offeringprnewswire.com · web

5 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Bluewhale do?: BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs. The company serves medical institutions and therapeutics developers working with cell therapy products.
Who are Bluewhale's investors?: Bluewhale's investors include Ascendo Ventures, Novalis LifeSciences, Baselayer Capital, Cardano, Ghaf Capital Partners, gumi Inc, PRIMAL CAPITAL, SBI Ven Capital and 1 more.
How much funding has Bluewhale raised?: Bluewhale has disclosed $5M raised across 1 of its 2 known rounds.
Where is Bluewhale headquartered?: Bluewhale is headquartered in Philadelphia, US.